Skip to content
Recall Observatory FDA recall evidence

Drug product

Cinacalcet Hydrochloride Tablets, 90 mg, 30 Tablets per bottle, Rx Only, Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059. NDC: 69097-412-02

D-0226-2026

November 14, 2025

Class II

Product summary

Firm
Cipla USA, Inc.
Event
Event 97974
Status
Ongoing
Classification
Class II
Quantity
12,576 bottles
Official record key
drug-enforcement:D-0226-2026

Official wording

Reason: CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable daily intake (ADI) limits.

Code information: Lot 5PB0183, exp 1/31/2027

Distribution pattern: Nationwide in the US

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    nitrosamine impurity
  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations